Uri Elia

853 total citations · 1 hit paper
32 papers, 612 citations indexed

About

Uri Elia is a scholar working on Molecular Biology, Infectious Diseases and Ecology. According to data from OpenAlex, Uri Elia has authored 32 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Infectious Diseases and 8 papers in Ecology. Recurrent topics in Uri Elia's work include Bacillus and Francisella bacterial research (13 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Bacteriophages and microbial interactions (8 papers). Uri Elia is often cited by papers focused on Bacillus and Francisella bacterial research (13 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Bacteriophages and microbial interactions (8 papers). Uri Elia collaborates with scholars based in Israel, Germany and United Kingdom. Uri Elia's co-authors include Dan Peer, Edo Kon, Ofer Cohen, Erez Bar‐Haim, Shahar Rotem, Eliezer Flescher, Hagai Cohen, Theodor Chitlaru, Ma’ayan Israeli and Gonna Somu Naidu and has published in prestigious journals such as Nature Communications, Nano Letters and Blood.

In The Last Decade

Uri Elia

31 papers receiving 602 citations

Hit Papers

Principles for designing an optimal mRNA lipid nanopartic... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Uri Elia Israel 13 398 213 121 97 56 32 612
Zakieh Sadat Hoseini Iran 6 280 0.7× 203 1.0× 127 1.0× 78 0.8× 85 1.5× 12 621
Christine Ludwig Germany 10 342 0.9× 188 0.9× 98 0.8× 114 1.2× 64 1.1× 12 577
Gholamreza Ahmadian Iran 8 305 0.8× 241 1.1× 138 1.1× 89 0.9× 94 1.7× 10 662
Enyue Fang China 6 249 0.6× 185 0.9× 90 0.7× 46 0.5× 20 0.4× 9 427
Fuxian Zhang China 12 182 0.5× 110 0.5× 105 0.9× 70 0.7× 56 1.0× 39 407
Clément R. Bouton United Kingdom 13 580 1.5× 347 1.6× 203 1.7× 116 1.2× 25 0.4× 22 955
Karnyart Samnuan United Kingdom 11 567 1.4× 379 1.8× 199 1.6× 115 1.2× 25 0.4× 12 857
Jeremy Luke United States 12 242 0.6× 127 0.6× 96 0.8× 192 2.0× 98 1.8× 15 421
Abigail E. Powell United States 8 247 0.6× 444 2.1× 118 1.0× 29 0.3× 42 0.8× 14 636
Natalie K. Connors Australia 10 205 0.5× 152 0.7× 61 0.5× 79 0.8× 154 2.8× 20 465

Countries citing papers authored by Uri Elia

Since Specialization
Citations

This map shows the geographic impact of Uri Elia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Uri Elia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Uri Elia more than expected).

Fields of papers citing papers by Uri Elia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Uri Elia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Uri Elia. The network helps show where Uri Elia may publish in the future.

Co-authorship network of co-authors of Uri Elia

This figure shows the co-authorship network connecting the top 25 collaborators of Uri Elia. A scholar is included among the top collaborators of Uri Elia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Uri Elia. Uri Elia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elia, Uri, Yinon Levy, Hagai Cohen, et al.. (2025). Novel Bivalent mRNA‐LNP Vaccine for Highly Effective Protection against Pneumonic Plague. Advanced Science. 12(26). e2501286–e2501286. 3 indexed citations
2.
Verbeke, Rein, Fabien Théry, Patrick J. Willems, et al.. (2025). Challenges and opportunities in mRNA vaccine development against bacteria. Nature Microbiology. 10(8). 1816–1828. 1 indexed citations
3.
Zilberzwige‐Tal, Shai, Aviad Levin, Assaf Ezra, et al.. (2025). On‐Chip De Novo Production of mRNA Vaccine in Lipid Nanoparticles. Small. 21(32). e2500114–e2500114. 1 indexed citations
5.
Cohen-Gihon, Inbar, Galia Zaide, Sharon Amit, et al.. (2024). Genome sequence of two novel virulent clinical strains of Burkholderia pseudomallei isolated from acute melioidosis cases imported to Israel from India and Thailand. BMC Genomic Data. 25(1). 47–47. 1 indexed citations
6.
Kon, Edo, Yinon Levy, Uri Elia, et al.. (2023). A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science Advances. 9(10). eadg1036–eadg1036. 61 indexed citations
7.
Elia, Uri, Edo Kon, & Dan Peer. (2023). CRISPR editing in the lung with novel lipids. Nature Biotechnology. 41(10). 1387–1388. 5 indexed citations
8.
Yahav, Dafna, Ruth Rahamimov, Tali Steinmetz, et al.. (2022). Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients—A Prospective Study. Transplant International. 35. 10204–10204. 18 indexed citations
9.
Israeli, Ma’ayan, Yaara Finkel, Yfat Yahalom-Ronen, et al.. (2022). Genome-wide CRISPR screens identify GATA6 as a proviral host factor for SARS-CoV-2 via modulation of ACE2. Nature Communications. 13(1). 2237–2237. 29 indexed citations
10.
Bar‐Haim, Erez, Noa Eliakim‐Raz, Amos Stemmer, et al.. (2022). Humoral and T-Cell Response before and after a Fourth BNT162b2 Vaccine Dose in Adults ≥60 Years. Journal of Clinical Medicine. 11(9). 2649–2649. 3 indexed citations
11.
Cohen, Hagai, Shahar Rotem, Uri Elia, et al.. (2022). T Cell Response following Anti-COVID-19 BNT162b2 Vaccination Is Maintained against the SARS-CoV-2 Omicron B.1.1.529 Variant of Concern. Viruses. 14(2). 347–347. 12 indexed citations
12.
Elia, Uri, Srinivas Ramishetti, Ronit Rosenfeld, et al.. (2021). Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles. ACS Nano. 15(6). 9627–9637. 84 indexed citations
13.
Bar‐Haim, Erez, Shahar Rotem, Uri Elia, et al.. (2019). Early Diagnosis of Pathogen Infection by Cell-Based Activation Immunoassay. Cells. 8(9). 952–952. 9 indexed citations
14.
Mechaly, Adva, Uri Elia, Ron Alcalay, et al.. (2019). Inhibition of Francisella tularensis phagocytosis using a novel anti-LPS scFv antibody fragment. Scientific Reports. 9(1). 11418–11418. 13 indexed citations
15.
Chitlaru, Theodor, Ma’ayan Israeli, Shahar Rotem, et al.. (2017). A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes. Vaccine. 35(44). 6030–6040. 13 indexed citations
16.
Zvi, Anat, Shahar Rotem, Ayelet Zauberman, et al.. (2017). Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague. Vaccine. 35(44). 5995–6006. 12 indexed citations
17.
Bar‐On, Liat, Hagai Cohen, Uri Elia, et al.. (2017). Protection of vaccinated mice against pneumonic tularemia is associated with an early memory sentinel-response in the lung. Vaccine. 35(50). 7001–7009. 4 indexed citations
18.
Chitlaru, Theodor, Ma’ayan Israeli, Erez Bar‐Haim, et al.. (2016). Next-Generation Bacillus anthracis Live Attenuated Spore Vaccine Based on the htrA- (High Temperature Requirement A) Sterne Strain. Scientific Reports. 6(1). 18908–18908. 20 indexed citations
19.
Elia, Uri & Eliezer Flescher. (2013). Combined Chemotherapy or Biotherapy with Jasmonates: Targeting Energy Metabolism for Cancer Treatment. Current Pharmaceutical Biotechnology. 14(3). 331–341. 11 indexed citations
20.
Elia, Uri & Eliezer Flescher. (2008). PI3K/Akt Pathway Activation Attenuates the Cytotoxic Effect of Methyl Jasmonate Toward Sarcoma Cells. Neoplasia. 10(11). 1303–1313. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026